Skip to main content
Clinical Trials/IRCT20231026059867N1
IRCT20231026059867N1
Not yet recruiting
Phase 2

Comparison of the effects of oral and injectable antiquaguane in the prevention of thromboembolic events in patients with gynecological cancers who underwent surgery.

Esfahan University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Condition 1: Thrombosis. Condition 2: Pulmonary embolism.
Sponsor
Esfahan University of Medical Sciences
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • People who have undergone surgery for gynecological cancers
  • Candidate to receive oral or injectable anticoagulants

Exclusion Criteria

  • Lack of consent to continue participating in the study
  • History of thromboembolic events

Outcomes

Primary Outcomes

Not specified

Similar Trials